Cesarean Delivery and Risk of Infant Leukemia: A Report from the Children's Oncology Group

Erin L Marcotte1,2, Michaela R Richardson3, Michelle A Roesler3

  • 1Division of Pediatric Epidemiology and Clinical Research, Department of Pediatrics, University of Minnesota, Minneapolis, Minnesota. marcotte@umn.edu.

Insights

Cesarean delivery (CD) is associated with an increased risk of infant acute lymphoblastic leukemia (ALL), but not acute myelogenous leukemia (AML). This study suggests a potential link between delivery method and childhood cancer risk.

Area of Science:

  • Pediatric Oncology
  • Epidemiology
  • Cancer Etiology

Background:

  • Previous studies indicate a higher risk of pediatric acute lymphoblastic leukemia (ALL) in children born via cesarean delivery (CD).
  • The specific impact of CD on infant leukemia risk remained unexamined.
  • Understanding delivery method influences on infant cancer is crucial for public health.

Purpose of the Study:

  • To investigate the association between cesarean delivery and the risk of infant acute leukemia (ALL and AML).
  • To analyze the impact of different cesarean delivery indications (pre-labor CD and emergency CD) on infant ALL risk.
  • To provide the first in-depth examination of CD and infant leukemia.

Main Methods:

  • A case-control study involving 443 infants diagnosed with acute leukemia and 324 controls.
  • Data collected via interviews and medical records.
  • Cesarean delivery analyzed overall and by indication (PLCD, ECD); logistic regression models used for risk estimation.

Main Results:

  • An increased risk estimate was observed for the association between CD and infant ALL (OR, 1.52; 95% CI, 1.02-2.25).
  • No significant association was found between CD and infant AML (OR, 1.02; 95% CI, 0.64-1.62).
  • Elevated risk estimates for infant ALL were associated with both pre-labor CD and emergency CD.

Conclusions:

  • Cesarean delivery, including both pre-labor and emergency types, is associated with an increased risk of infant ALL.
  • The findings suggest a potential role for altered microbiota colonization in the development of infant leukemia.
  • Further research is needed to elucidate the biological mechanisms linking CD to infant ALL.

Related Concept Videos

Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...